definiens: shall not include applications for pricing, and reimburscmentllpproval . 1.!'i2 with respect to any Drug Product shall mean the gross amount invoiced by [COMPANY] and any [COMPANY] Affiliate, or Sublicensee, as the c.ase may be, for that Drug Product in connection with sales to Third Parties in bona fide, arms - length transactions, less ( i ) trade, quantity and/or cash discounts from the gross invoice price which are actuall ), allowed or taken ; ( ii ) freight, postage and inslll1Lnce included in the invoice price and that are customary for the industry ; ( iii ) amounts repaid or credited by reasons of rejections or return of goods or because : of retroactive price reductions specifically identifiable to the Drug Product ; ( iv ) amounts payable resulting from government ( or agency thereot ) mandated rebate programs with respect to the Drug Product being invoiced ; ( v ) Third Part ) ' rebates and charge - backs to the elltent actually lawfully allowed ; f'o'i ) i. 80Pdally llaMHiRJ Bireelly NlaloB Ie TIll sale ; Rilil ( vii ) 8JRetint ! ! ! ; HelTe elleenl in the 8ggt'!gBU BIl81l8runT ( U~~ ) OnieT Sal~ in any ene yea, ) Btililtd en aeeelllli eh ~ eaiHe il8B~ eMpefi ~ nee!:l willi respeel Ie ; Old Sales eieea allB as III ' " I, iell the relatd F'Et)·alt)l ila~ ~eell paiate VerteN. alias determined in accordance with generally aaepted accounting principles ( ), consistently applied by [COMPANY]